Cognition Therapeutics annual operating expenses
2020
2021
2022
2023
2024
2025
Cognition Therapeutics Operating Expenses Growth & History (CGTX)
Cognition Therapeutics's operating expenses was $47.8M for fiscal 2025.
View full Cognition Therapeutics company overviewCognition Therapeutics annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $47.8M | −$6.2M | −11.43% |
| 2024 | 2024-12-31 | $54.0M | $3.2M | +6.39% |
| 2023 | 2023-12-31 | $50.7M | $7.2M | +16.47% |
| 2022 | 2022-12-31 | $43.6M | $15.0M | +52.29% |
| 2021 | 2021-12-31 | $28.6M | $11.2M | +64.29% |
| 2020 | 2020-12-31 | $17.4M | — | — |
Cognition Therapeutics quarterly operating expenses
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $7.7M | −$6.2M | −44.64% |
| Q1 2026 | 2026-03-31 | $8.8M | −$5.0M | −35.99% |
| Q4 2025 | 2025-12-31 | $13.7M | $2.9M | +27.49% |
| Q3 2025 | 2025-09-30 | $6.4M | −$8.1M | −55.92% |
| Q2 2025 | 2025-06-30 | $14.0M | −$700,000 | −4.77% |
| Q1 2025 | 2025-03-31 | $13.8M | −$327,000 | −2.32% |
| Q4 2024 | 2024-12-31 | $10.7M | −$4.5M | −29.40% |
| Q3 2024 | 2024-09-30 | $14.5M | −$282,000 | −1.91% |
| Q2 2024 | 2024-06-30 | $14.7M | $2.9M | +24.21% |
| Q1 2024 | 2024-03-31 | $14.1M | $5.1M | +57.16% |
| Q4 2023 | 2023-12-31 | $15.2M | $5.9M | +63.32% |
| Q3 2023 | 2023-09-30 | $14.7M | $2.1M | +16.79% |
| Q2 2023 | 2023-06-30 | $11.8M | −$396,000 | −3.24% |
| Q1 2023 | 2023-03-31 | $9.0M | −$440,000 | −4.67% |
| Q4 2022 | 2022-12-31 | $9.3M | −$2.5M | −21.24% |
| Q3 2022 | 2022-09-30 | $12.6M | $7.4M | +141.72% |
| Q2 2022 | 2022-06-30 | $12.2M | $6.2M | +104.09% |
| Q1 2022 | 2022-03-31 | $9.4M | $3.8M | +68.60% |
| Q4 2021 | 2021-12-31 | $11.8M | — | — |
| Q3 2021 | 2021-09-30 | $5.2M | $762,000 | +17.08% |
| Q2 2021 | 2021-06-30 | $6.0M | — | — |
| Q1 2021 | 2021-03-31 | $5.6M | — | — |
| Q3 2020 | 2020-09-30 | $4.5M | — | — |
Cognition Therapeutics operating expenses trends
Over the last five fiscal years, Cognition Therapeutics's operating expenses increased from $17.4M to $47.8M, a change of $30.4M. The latest reported quarter, Q2 2026, shows $7.7M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cognition Therapeutics source filings ↗